Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

SK BIOSCIENCE CO.,LTD.

(A302440)
  Rapport
SynthèseGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsFondsCommunauté 
SynthèseToute l'actualitéAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur SK BIOSCIENCE CO.,LTD.
08/11South Korea Stocks Decline as Investors Eye US, China Inflation Data; Biopharma Stocks ..
08/11S.Korean stocks end at near 1-month low as biopharma shares slump
28/10GSK delivers strong Q3 sales of GBP9.1 billion +5% AER, +10% CER Total EPS 23.3p -7% AE..
20/09SK BIOSCIENCE CO.,LTD.(KOSE : A302440) added to FTSE All-World Index
20/09SK BIOSCIENCE CO.,LTD.(KOSE : A302440) added to S&P Global BMI Index
07/09Vaccine makers should supply shots for trials to help spur sector -CEPI
31/08GlaxoSmithKline y SK Bioscience inician ensayo de Fase 3 de vacuna Covid-19
31/08GSK y SK Bioscience evaluarán su vacuna contra la COVID-19 frente a la de AZ
31/08MÄRKTE ASIEN/Fester - Kospi von Samsung-Aktie angetrieben
31/08GlaxoSmithKline, SK Bioscience Begin Phase 3 Trial of Covid-19 Vaccine
31/08S. Korean COVID-19 vaccine in late-stage test against AstraZeneca shot
31/08SK Bio, GSK Start Late-Stage COVID-19 Vaccine Trial
31/08SK BIOSCIENCE : GSK, SK Bioscience start late-stage trials of COVID-19 vaccine
10/08South Korea approves Phase III trial of SK Bioscience's COVID-19 vaccine
05/08S.Korea pledges nearly $2 bln to become major COVID-19 vaccine producer
21/06SK BIOSCIENCE : S.Korea's SK bioscience to invest $132 million to boost vaccine production
11/06SK BIOSCIENCE CO.,LTD.(KOSE : A302440) added to KOSPI 200 Index
03/06MÄRKTE ASIEN/Überwiegend aufwärts - China-Börsen mit Abgaben
25/05MÄRKTE ASIEN/Börsen steigen mit schwindenden Zinsängsten
25/05MÄRKTE ASIEN/Technologiewerte führen Börsen an
24/05NOVAVAX : Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine A..
24/05Samsung BioLogics shares ease after jumping on vaccine deal
22/05U.S. vaccine makers agree to produce more COVID-19 vaccines in South Korea
21/05VIR BIOTECHNOLOGY : EMA issues positive scientific opinion on GSK and Vir Biotechnology's ..
18/05MÄRKTE ASIEN/Fest - Börsianer setzen auf Wachstum - Stahlwerte gesucht
18/05MÄRKTE ASIEN/Fest - Erholungshausse in Taiwan
17/05SK bioscience's COVID-19 vaccine plant in South Korea gets European nod
10/05VIR BIOTECHNOLOGY : GSK and Vir Biotechnology announce the start of the EMA rolling review..
19/04MÄRKTE ASIEN/Überwiegend positive Stimmung an Börsen dank US-Rekorden
19/04MÄRKTE ASIEN/Positive Stimmung an den Börsen dank US-Rekorden
13/04MÄRKTE ASIEN/Gewinne in Tokio und Seoul - Schanghai leichter
13/04MÄRKTE ASIEN/Erholt - Handelsbilanzdaten bremsen Schanghai
12/04S.Korea to begin producing Novavax COVID-19 vaccine as early as June
09/04MÄRKTE ASIEN/Börsen mit moderaten Einbußen - Tokio gut behauptet
09/04MÄRKTE ASIEN/Abwärtstendenz zum Wochenausklang - Sony-Aktie steigt
12/03SK bioscience Co.,Ltd. has completed an IPO in the amount of KRW 1.49175 trillion.
05/02SK bioscience Co.,Ltd. has filed an IPO in the amount of KRW 1.49175 trillion.
2020SK Bioscience to Build Vaccines Platform for Future Virus Spreads